Exploring the potential of P-glycoprotein inhibitors in the targeted delivery of anti-cancer drugs: A comprehensive review
Authors:
- 20 March 2024
- journal article
- review article
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 198, 114267
Abstract
No abstract availableKeywords
This publication has 102 references indexed in Scilit:
- ABCB1/MDR1/P‐gp employs an ATP‐dependent twist‐and‐squeeze mechanism to export hydrophobic drugsFEBS Letters, 2020
- Nanogels as Pharmaceutical Carriers: Finite Networks of Infinite CapabilitiesAngewandte Chemie International Edition, 2009
- Potential Oral Delivery of 7-Ethyl-10-Hydroxy-Camptothecin (SN-38) using Poly(amidoamine) DendrimersPharmaceutical Research, 2008
- Lipid Formulation Strategies for Enhancing Intestinal Transport and Absorption of P-Glycoprotein (P-gp) Substrate Drugs: In vitro/In vivo Case StudiesJournal of Pharmaceutical Sciences, 2007
- Recent Progress in Understanding the Mechanism of P-Glycoprotein-mediated Drug EffluxThe Journal of Membrane Biology, 2005
- Molecular mechanisms of drug resistanceThe Journal of Pathology, 2005
- Exploring the structure and function of the P-glycoprotein multidrug transporter using fluorescence spectroscopic toolsSeminars in Cell & Developmental Biology, 2001
- How does P-glycoprotein recognize its substrates?Seminars in Cancer Biology, 1997
- Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P‐glycoprotein: Implications for drug delivery and activity in cancer chemotherapyMolecular Carcinogenesis, 1995
- Uptake of doxorubicin from loaded nanoparticles in multidrug-resistant leukemic murine cellsCancer Chemotherapy and Pharmacology, 1994